Financials

  • Market Capitalization 10.73 B
  • Employee 691
  • Founded 2014
  • CEO Rich Adcock
  • Website www.immunitybio.com
  • Headquarter Delaware, United States
  • FIGI BBG007T9DYW9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.21
Rapporto prezzo/fatturato
16.08

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
822
TECH
Bio-Techne Corp - Common Stock
72.56 USD+0.14%-0.03%+0.48%+23.55%11.38 B USD
848
MDGL
Madrigal Pharmaceuticals, Inc. - Common Stock
467.16 USD-0.97%-6.02%-13.49%+10.28%10.79 B USD
852
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
55.39 USD+1.08%-3.74%-16.71%+6.97%10.72 B USD
868
PCVX
Vaxcyte, Inc. - Common Stock
70.65 USD-1.02%-3.68%+17.67%+67.02%10.51 B USD

Notizie